UMeWorld filed a notice on February 2, 2026 that its quarterly report for the quarter ended December 31, 2025 will be late. Its auditor, J&S Associate PLT, resigned on December 31, 2025, and the company has not yet engaged a successor, so the review of its interim results has not started.
UMeWorld moved its legal home from the British Virgin Islands to Delaware, changed its name and began trading as UMEW on the OTC Markets on January 21, 2026. Its annual report for the year ended September 30, 2025 includes a going concern warning.
Latest balance sheet, Jun 30, 2026 (10-Q): cash and equivalents $86,259.
Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice.
Questions about UMeWorld
Has UMeWorld issued a going-concern warning?
Our latest story on this, dated Jan 21, 2026: "UMeWorld begins trading on OTC Markets as UMEW after move to Delaware". The story links the filing or release it is based on. Read the story.
What is the ticker symbol of UMeWorld?
UMeWorld Inc. trades under the ticker UMEW on OTC.
Where is UMeWorld listed?
UMeWorld Inc. is listed on OTC.
What is the SEC CIK of UMeWorld?
The SEC Central Index Key (CIK) for UMeWorld Inc. is 1114936. Its filings are on SEC EDGAR.
How many shares does UMeWorld have outstanding?
116,099,593 shares as of 2026-08-05, per the cover page of its 10-Q filed 2026-08-13.
Which country or territory is UMeWorld listed under?
Our directory records UMeWorld Inc. under United States.
What does UMeWorld do?
Our directory classifies UMeWorld Inc. as: Biotechnology. This is a directory classification, not a description of the pipeline.
What is the ISIN of UMeWorld?
The ISIN recorded for UMeWorld Inc. is US90292A1051.
Does aibio.space cover UMeWorld?
aibio.space lists UMeWorld Inc. among 2,820 public biotech companies and publishes its news here as stories appear.
Where is UMeWorld incorporated?
SEC records list its state or country of incorporation as DE.
What was UMeWorld's revenue last year?
$2,222 for the fiscal year ended Sep 30, 2025, as reported to the SEC.
Is UMeWorld profitable?
UMeWorld Inc. reported a net loss of $258,176 for the fiscal year ended Sep 30, 2025, and used $113,946 of cash in operations, per its annual report to the SEC.
How much cash does UMeWorld have?
$86,259 in cash at Jun 30, 2026, per its 10-Q.
What is the latest UMeWorld (UMEW) stock news?
Our latest story on UMeWorld, dated Feb 2, 2026: "UMeWorld (formerly UMeWorld Limited) says 10-Q is late after auditor resigned". UMeWorld filed a notice on February 2, 2026 that its quarterly report for the quarter ended December 31, 2025 will be late. Its auditor, J&S Associate PLT, resigned on December 31, 2025, and the company has not yet engaged a successor, so the review of its interim results has not started. Source.
How long will UMeWorld's cash last?
From our story of Feb 2, 2026: The notes say those losses, a stockholders' deficit of $323,911 and reliance on outside financing raise substantial doubt about the company's ability to continue as a going concern. Source.
Investor discussion: UMeWorld
Members talk about UMeWorld (UMEW). Reader posts, not aibio.space reporting, and not investment advice.
Rules
Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
Say whether you hold the stock. Every post states long, short or no position.
No paid or sponsored posts. Do not post for anyone who pays or rewards you.
No buy or sell calls and no price targets.
No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
No personal details and no spam. No links at all for your first 7 days as a member.
Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.
Capital-markets timeline
Financings, listing notices, splits, legal actions and other investor events at UMeWorld, newest first. Each line links the filing it comes from.
Legal
Reported a change of independent auditor. SEC Form 8-K (Items 4.01). Source
Distress
Told the SEC a periodic report would be filed late. SEC Form NT 10-Q. Source
Listings
Reported a notice from its stock exchange about continued listing requirements. SEC Form 8-K (Items 3.01,5.03,7.01,8.01,9.01). Source
Legal
Reported a change of independent auditor. SEC Form 8-K (Items 4.01,9.01). Source
Stock chart
Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open OTC:UMEW on TradingView.
SEC filings and registration
SEC name
UMeWorld Inc.
CIK
1114936
Industry (SIC)
Services-Prepackaged Software (7372)
US tickers
UMEW (OTC)
State or country of incorporation
DE
Fiscal year ends
September 30
Filer category
Non-accelerated filer<br>Smaller reporting company
Business address
UNIT B 12/F, HANG SENG, CAUSEWAY BAY, 00000
Phone
(852) 8191 5550
Shares outstanding
116,099,593 as of 2026-08-05 (10-Q filed 2026-08-13)
Former names
UMeWorld Ltd; ALPHARX INC
Recent filings (8-K and 6-K are the company's own announcements)
Source: SEC EDGAR, retrieved October 23, 2026. Shares outstanding is the cover-page figure from the latest periodic report. The SEC does not publish share prices.
Listing details
UMeWorld Inc. is a public biotech or pharmaceutical company listed on OTC under the ticker UMEW, recorded under United States. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.
Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.
Published and maintained by aibio.space. Not investment advice. How we work.
Who manages this pageThis page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction
aibio